Sanderling Venture Partners VI LP 13D/13G Filings for CalciMedica, Inc. (CALC)

Sanderling Venture Partners VI LP 13D and 13G filings for CalciMedica, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-11-26
06:03 am
Purchase
2023-03-20 13D CalciMedica, Inc.
CALC
Sanderling Venture Partners VI LP 2,550,550
18.300%
2,550,550increase
(New Position)
Filing